Rasagiline interferes with neurodegeneration in the Prph2/rds mouse

Retina

Volumn 32, Issue 3, 2012, Pages 617-628

  Eigeldinger Berthou, Sylvie ^a   Meier, Claudia ^a   Zulliger, Rahel ^a   Lecaudé, Stéphanie ^a   Enzmann, Volker ^a   Sarra, Gian Marco ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; RASAGILINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOPHAGY; CONTROLLED STUDY; DOSE RESPONSE; DRUG BIOAVAILABILITY; ENZYME INHIBITION; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MARKER GENE; MORPHOMETRICS; MOUSE; NEUROPROTECTION; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PHOTORECEPTOR CELL; RETINA DEGENERATION; THICKNESS;

ADMINISTRATION, ORAL; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL DEATH; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; INDANS; MICE; MICE, TRANSGENIC; NEUROPROTECTIVE AGENTS; REAL-TIME POLYMERASE CHAIN REACTION; RETINAL DEGENERATION; RETINAL PHOTORECEPTOR CELL OUTER SEGMENT;

EID: 84858070752     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e31821e2070     Document Type: Article

References (37)

1. Doonan F, Cotter TG. Apoptosis: a potential therapeutic target for retinal degenerations. Curr Neurovasc Res 2004;1: 41-53.
2. Lohr HR, Kuntchithapautham K, Sharma AK, et al. Multiple, parallel cellular suicide mechanisms participate in photoreceptor cell death. Exp Eye Res 2006;83:380-389. (Pubitemid 43850954)
3. Chang B, Hawes NL, Hurd RE, et al. Retinal degeneration mutants in the mouse. Vision Res 2002;42:517-525. (Pubitemid 34169709)
4. Sanyal S, Jansen HG. Absence of receptor outer segments in the retina of rds mutant mice. Neurosci Lett 1981;21:23-26. (Pubitemid 11178780)
5. Dryja TP, Hahn LB, Kajiwara K, et al. Dominant and digenic mutations in the peripherin/RDS and ROM1 genes in retinitis pigmentosa. Invest Ophthalmol Vis Sci 1997;38:1972-1982. (Pubitemid 27407516)
6. Boon CJ, den Hollander AI, Hoyng CB, et al. The spectrum of retinal dystrophies caused by mutations in the peripherin/RDS gene. Prog Retin Eye Res 2008;27:213-235.
7. Travis GH. Mechanisms of cell death in the inherited retinal degenerations. Am J Hum Genet 1998;62:503-508. (Pubitemid 28164605)
8. McGee Sanftner LH, Abel H, Hauswirth WW, et al. Glial cell line derived neurotrophic factor delays photoreceptor degeneration in a transgenic rat model of retinitis pigmentosa. Mol Ther 2001;4:622-629. (Pubitemid 34026878)
9. Sieving PA, Caruso RC, Tao W, et al. Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants. Proc Natl Acad Sci U S A 2006;103:3896-3901. (Pubitemid 43376652)
10. Schlichtenbrede FC, Macneil A, Bainbridge JW, et al. Intraocular gene delivery of ciliary neurotrophic factor results in significant loss of retinal function in normal mice and in the Prph2Rd2/Rd2 model of retinal degeneration. Gene Ther 2003;10:523-527. (Pubitemid 36395269)
11. Chen JJ, Swope DM. Clinical pharmacology of rasagiline: a novel, second-generation propargylamine for the treatment of Parkinson disease. J Clin Pharmacol 2005;45:878-894. (Pubitemid 41060227)
12. Eliash S, Speiser Z, Cohen S. Rasagiline and its (S) enantiomer increase survival and prevent stroke in salt-loaded stroke-prone spontaneously hypertensive rats. J Neural Transm 2001;108: 909-923. (Pubitemid 32802090)
13. Eliash S, Shteter N, Eilam R. Neuroprotective effect of rasagiline, amonoamine oxidase-B inhibitor, on spontaneous cell degeneration in a rat model. J Neural Transm 2005;112:991-1003. (Pubitemid 40991515)
14. Kupsch A, Sautter J, Gotz ME, et al. Monoamine oxidaseinhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline. J Neural Transm 2001;108:985-1009. (Pubitemid 32802096)
15. Waibel S, Reuter A, Malessa S, et al. Rasagiline alone and in combination with riluzole prolongs survival in an ALS mouse model. J Neurol 2004;251:1080-1084. (Pubitemid 39297202)
16. Youdim MB, Bar AO, Yogev-Falach M, et al. Rasagiline: neurodegeneration, neuroprotection, and mitochondrial permeability transition. J Neurosci Res 2005;79:172-179. (Pubitemid 40116432)
17. Mandel S, Weinreb O, Amit T, et al. Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivates. Brain Res Rev 2005;48:37.
18. Speiser Z, Katzir O, RehaviM, et al. Sparing by rasagiline (TVP- 1012) of cholinergic functions and behavior in the postnatal anoxia rat. Pharmacol Biochem Behav 1998;60:387-393. (Pubitemid 28282679)
19. Tipton KF, Youdim MBH. Assay of Monoamine Oxidases. Amsterdam: North Holland; 1983:442-465.
20. Strosznajder J, Chalimoniuk M, Strosznajder RP, et al. Arachidonate transport through the blood-retina and blood-brain barrier of the rat during aging. Neurosci Lett 1996;209:145-148. (Pubitemid 26164948)
21. Young RW. Cell death during differentiation of the retina in the mouse. J Comp Neurol 1984;229:362-373. (Pubitemid 15201535)
22. Kunchithapautham K, Rohrer B. Apoptosis and autophagy in photoreceptors exposed to oxidative stress. Autophagy 2007;3: 433-441. (Pubitemid 47293724)
23. Sarra GM, Sarra FG, Schlichtenbrede FC, et al. Effect of steroidal and non-steroidal drugs on the microglia activation pattern and the course of degeneration in the retinal degeneration slow mouse. Ophthalmic Res 2005;37:72-82. (Pubitemid 40868732)
24. Weinreb O, Amit T, Bar-Am O, et al. Novel neuroprotective mechanism of action of rasagiline is associated with its propargyl moiety: interaction of Bcl-2 family members with PKC pathway. Ann N Y Acad Sci 2005;1053:348-355. (Pubitemid 43031115)
25. Sanyal S, De Ruiter A, Hawkins RK. Development and degeneration of retina in rds mutant mice: light microscopy. J Comp Neurol 1980;194:193-207. (Pubitemid 11212701)
26. Jeon CJ, Strettoi E, Masland RH. The major cell populations of the mouse retina. J Neurosci 1998;18:8936-8946. (Pubitemid 28491758)
27. Guay DR. Rasagiline (TVP-1012): a new selective monoamine oxidase inhibitor for Parkinsons disease. Am J Geriatr Pharmacother 2006;4:330-346. (Pubitemid 46222213)
28. Lev S. Molecular aspects of retinal degenerative diseases. Cell Mol Neurobiol 2001;21:575-589. (Pubitemid 34538856)
29. Marigo V. Programmed cell death in retinal degeneration: targeting apoptosis in photoreceptors as potential therapy for retinal degeneration. Cell Cycle 2007;6:652-655. (Pubitemid 46535674)
30. Sancho-Pelluz J, Arango-Gonzalez B, Kustermann S, et al. Photoreceptor cell death mechanisms in inherited retinal degeneration. Mol Neurobiol 2008;38:253-269.
31. Doonan F, Donovan M, Cotter TG. Caspase-independent photoreceptor apoptosis in mouse models of retinal degeneration. J Neurosci 2003;23:5723-5731. (Pubitemid 36807851)
32. Ferraro E, Cecconi F. Autophagic and apoptotic response to stress signals in mammalian cells. Arch Biochem Biophys 2007;462:210-219. (Pubitemid 46856320)
33. Erlich S, Shohami E, Pinkas-Kramarski R. Neurodegeneration induces upregulation of Beclin 1. Autophagy 2006;2: 49-51.
34. Samardzija M, Wenzel A, Thiersch M, et al. Caspase-1 ablation protects photoreceptors in a model of autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci 2006;47:5181-5190. (Pubitemid 46723763)
35. Lupien C, Brenner M, Guerin SL, et al. Expression of glial fibrillary acidic protein in primary cultures of human Muller cells. Exp Eye Res 2004;79:423-429. (Pubitemid 39164479)
36. Yang C, Kaushal V, Haun RS, et al. Transcriptional activation of caspase-6 and -7 genes by cisplatin-induced p53 and its functional significance in cisplatin nephrotoxicity. Cell Death Differ 2008;15:530-544. (Pubitemid 351267304)
37. Takahashi K, Rochford CD, Neumann H. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J Exp Med 2005; 201:647-657. (Pubitemid 40289554)